People, every show

Hugo Garcia-Cotte

CEO and Co-Founder, Cypheme. On 1 show, 1 appearance. The Shows tab opens the full record on each.

founderexecutivecypheme.com ↗

Hugo Garcia-Cotte founded Cypheme in 2015 to tackle counterfeit goods and pharmaceuticals using computer vision and machine learning that verifies unique microstructures through smartphone cameras. An alumnus of CentraleSupélec and Tsinghua University, he previously ran Five-Doors and has led Cypheme through incubators and accelerators, including Station F in Paris.

1shows
1appearances
11statements
2resolved
1supported
1contradicted
50%fully supported
1said about them ↓

Everything Hugo Garcia-Cotte said on any show that made the record, most notable first. Each card names its show and opens the statement there.

Garcia-Cotte: Western brands severely distrust Chinese startups for anti-counterfeiting solutions
“Like, obviously, a Chinese team would have a hard time convincing Western brands that they are trustworthy for anti-counterfeiting. It's sad to say, but it's the reality.”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 15:29 45% of This Cancer Drug Was Fake — Here's How We Proved It
Garcia-Cotte: 99% of business books are poisonous trash by non-practitioners
“99% of business books are trash. Trash, trash, trash. Actually, it's worse if you read them than if you don't read them, because if you read them, you get poisonous thoughts, and not only you wasted your time reading it, that's okay, it's just a few hours, but…”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 30:35 45% of This Cancer Drug Was Fake — Here's How We Proved It
Garcia-Cotte: Anti-counterfeiting competitors lack tech DNA and hire second-rate CTOs
“Cause a lot of competitors, they don't even come from a tech background. They come from a printing background. They come from a hologram background. They have no idea about computer science. So then they hire a second-rate CTO, and they don't coach him well, a…”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 14:20 45% of This Cancer Drug Was Fake — Here's How We Proved It
Garcia-Cotte: CEOs cannot delegate hiring until reaching 1,000 employees
“Hiring is not something you can delegate. It's your job as the CEO until you're a thousand employees.”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 28:18 45% of This Cancer Drug Was Fake — Here's How We Proved It
Garcia-Cotte: French public universities are poor compared to Grandes Écoles
“French universities are not good. The good students, they go to elite schools, but these are not schools you pay for. Like, to go there, you have very tough competitions, and most of them are free.”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 5:12 45% of This Cancer Drug Was Fake — Here's How We Proved It
WE LIVE TO BUILD Assertion Contradicted
Garcia-Cotte: Cypheme Raised the Largest French Angel Round at That Time
“Then everybody turned to yes, and then we made the biggest angel round in France at that time.”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 24:07 45% of This Cancer Drug Was Fake — Here's How We Proved It
WE LIVE TO BUILD Assertion Not checkable as stated
Garcia-Cotte: 45% of Protected Anti-Cancer Medicine in China Was Counterfeit
“So then they started using our product, and we realized that not only they had some fakes, but actually they had 45% fakes in the market.”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 35:49 45% of This Cancer Drug Was Fake — Here's How We Proved It
WE LIVE TO BUILD Assertion Not checkable as stated
Garcia-Cotte: Cypheme's intelligence led Chinese police to jail 18 counterfeiters
“18 criminals were sent to jail thanks to the intel we provided them, and we had no idea.”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 38:53 45% of This Cancer Drug Was Fake — Here's How We Proved It
Garcia-Cotte: Do Not Start a Company Without 24 Months of Runway
“If you cannot afford to be without resource or with some resource on the side for 24 months, if you're gonna give up before 24 months, don't even start. Because that's what it will take for you to start having a company.”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 42:41 45% of This Cancer Drug Was Fake — Here's How We Proved It
WE LIVE TO BUILD Assertion Supported
Garcia-Cotte: Uncle's 12-color camera scanned Mona Lisa and revealed Da Vinci's underdrawing
“One of my uncles invented a camera that can analyze paintings in 12 colors instead of three. So a normal camera just take three colors, RGB, and then save that. He invented a camera that can scan in 12 colors, and he struggled for years to sell it, and he didn…”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 6:28 45% of This Cancer Drug Was Fake — Here's How We Proved It
WE LIVE TO BUILD Assertion Not checkable as stated
Garcia-Cotte: 99 Out of Almost 100 Investors Rejected Cypheme's First Round
“Actually, within those six months, I've maybe met a little less than a hundred investors, and it was insanely hard because it was three, four, five, six, sometimes seven meetings a day pitching our company, and out of these 100 people, 99 of them said no.”
Hugo Garcia-Cotte Dec 28, 2020 ▶ 22:48 45% of This Cancer Drug Was Fake — Here's How We Proved It

The other half of the tape: Hugo Garcia-Cotte's own voice is left out of every number here. Other people bring the name up 1 time in 1 episode across the shows. every mention, with the transcript →

Who brings them up most Sean Weisbrot 1

Every mention by year

tap a year for its mentions
0011112021episodesmentions
0112021episodes it came up in
000.50.5112021episodesmentions per episode

We Live to Build 1

2021 1 mention in 1 episode

One line per show, most statements first. The link opens Hugo's full record on that show: the calibration, argument clarity, speaking style and every statement made there.

ShowRole thereEpsStatementsRecord
WE LIVE TO BUILDLEDGER CEO and Co-Founder, Cypheme 1 11 50% 1/2 full record on We Live to Build →
Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.